![](/img/cover-not-exists.png)
Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: an integrated analysis of Phase 2 and 3 trials
Harigai, Masayoshi, Takeuchi, Tsutomu, Smolen, Josef S., Winthrop, Kevin L, Nishikawa, Atsushi, Rooney, Terence P, Saifan, Chadi G, Issa, Maher, Isaka, Yoshitaka, Akashi, Naotsugu, Ishii, Taeko, TanakJournal:
Modern Rheumatology
DOI:
10.1080/14397595.2019.1583711
Date:
February, 2019
File:
PDF, 620 KB
2019